Embecta Corp.(EMBC)Stock Analysis
AI analysis on 2,800+ stocks →Deep AI analysis on 2,800+ stocks →13F Pro Quality Score
Rank #1,618 of 2,962 stocks
Rankings refresh quarterly once 80% of peers have filed (~45 days after quarter-end). Next update: ~Nov 14, 2026.
Revenue Growth
Profitability
Balance Sheet
Earnings Quality
Free Cash Flow
Institutional Flow
Revenue Scale
Dilution Risk
Unusual Activity in EMBC
Events flagged as statistical outliers against EMBC's own multi-year baseline — not fixed dollar thresholds.
- Insider cluster2026-08-12
4 insiders bought $557,945 of EMBC in 30 days — 8.0σ above this company's 2-year norm
View source filing →
EMBC Stock Analysis & AI Quality Score
Data updated 2026-09-11AI stock analysis and institutional research for Embecta Corp. (EMBC), a Healthcare sector company. 13F Pro's AI-powered ranking engine scores EMBC at 50.2/100 on a 32-signal composite quality model, placing it at rank #1,618 of 2,962 stocks — the bottom half of the AI-ranked universe. EMBC scores in the top quartile across earnings quality (84.0), balance sheet strength (78.2). Areas of concern include institutional flow (3.8) and revenue growth (13.4), which score below median versus the broader universe. Shareholder dilution risk is elevated at 33.2/100, reflecting ongoing share issuance or stock-based compensation. Based on the latest XBRL financial filings (Q2 2026), Embecta Corp. reports quarterly revenue of $271.7M, net income of $21.1M, free cash flow of $40.7M. Top institutional holders of EMBC by reported 13-F value include BlackRock, YACKTMAN ASSET MANAGEMENT, VANGUARD CAPITAL MANAGEMENT, based on the most recent SEC filings. EMBC trades on the Nasdaq exchange and files with the SEC under CIK 1872789. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate EMBC daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for Embecta Corp. directly from SEC EDGAR. Embecta Corp.'s 13F Pro composite quality score has ranged between 42 and 64 since 2022, currently 50.2 — a declining long-term trajectory across 61 quarterly and live scoring snapshots.
Revenue
Q2 2026
$271.7M
Net Income
Q2 2026
$21.1M
Free Cash Flow
Q2 2026
$40.7M
ROIC
Q2 2026
23.1%
Revenue & Net Income
Earnings Per Share
Key Financials Over Time
Export Financial Table · ProRevenue
-3.8% YoYNet Income
+21.8% YoYOperating Income
+45.1% YoYEPS (Diluted)
+20.9% YoYTotal Assets
-15.1% YoYTotal Debt
-11.1% YoYOp. Cash Flow
+437.0% YoYFree Cash Flow
+816.6% YoY| Metric | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Revenue | $1.08B -3.8% | $1.12B +0.2% | $1.12B -0.8% | $1.13B -3.1% | $1.17B +7.4% | $1.09B |
| Net Income | $95.4M +21.8% | $78.3M +11.2% | $70.4M -68.5% | $223.6M -46.1% | $414.8M -3.0% | $427.6M |
| Operating Income | $242.1M +45.1% | $166.8M -24.7% | $221.5M -28.5% | $309.6M -37.1% | $492.0M +1.1% | $486.5M |
| EPS (Diluted) | $1.62 +20.9% | $1.34 +9.8% | $1.22 -68.6% | $3.89 -46.6% | $7.28 -2.9% | $7.50 |
| Total Assets | $1.09B -15.1% | $1.29B +5.8% | $1.21B +11.8% | $1.09B +37.9% | $788.0M | — |
| Total Debt | $1.41B -11.1% | $1.58B -1.2% | $1.60B -0.3% | $1.61B | $0.00 | $0.00 |
| Operating Cash Flow | $191.7M +437.0% | $35.7M -47.3% | $67.7M -83.6% | $412.2M -9.7% | $456.3M -8.5% | $498.5M |
| Free Cash Flow | $182.4M +816.6% | $19.9M -51.7% | $41.2M -89.4% | $388.6M -7.4% | $419.5M -8.1% | $456.6M |
Get alerted when EMBC's score changes
Free account: watchlist tracking, the daily AI brief, and the AI screener.
Available Research
13F Pro tracks comprehensive data for Embecta Corp. including:
Top Institutional Holders of EMBC
BlackRock, Inc.
$15.0M4,599,771 shYACKTMAN ASSET MANAGEMENT LP
$14.1M4,315,952 shVANGUARD CAPITAL MANAGEMENT LLC
$8.3M2,557,148 shDEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)
$8.3M2,534,961 shLEUCADIA NATIONAL CORP
$7.7M2,355,117 shAMERIPRISE FINANCIAL INC
$6.6M2,038,731 shMORGAN STANLEY
$6.5M1,996,747 shSTATE STREET CORP
$5.3M1,610,666 shGEODE CAPITAL MANAGEMENT, LLC
$5.2M1,594,457 shBRIGADE CAPITAL MANAGEMENT, LP
$4.9M1,516,453 sh
| Fund | Value | Shares |
|---|---|---|
| BlackRock, Inc. | $15.0M | 4,599,771 |
| YACKTMAN ASSET MANAGEMENT LP | $14.1M | 4,315,952 |
| VANGUARD CAPITAL MANAGEMENT LLC | $8.3M | 2,557,148 |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | $8.3M | 2,534,961 |
| LEUCADIA NATIONAL CORP | $7.7M | 2,355,117 |
| AMERIPRISE FINANCIAL INC | $6.6M | 2,038,731 |
| MORGAN STANLEY | $6.5M | 1,996,747 |
| STATE STREET CORP | $5.3M | 1,610,666 |
| GEODE CAPITAL MANAGEMENT, LLC | $5.2M | 1,594,457 |
| BRIGADE CAPITAL MANAGEMENT, LP | $4.9M | 1,516,453 |
Companies Similar to EMBC
Ranked by quality-profile closeness and shared hedge-fund ownership — not just sector membership.
Lantheus Holdings, Inc.
Amphastar Pharmaceuticals, Inc.
InMode Ltd.
PUMA BIOTECHNOLOGY, INC.
HOLOGIC INC
Organon & Co.
GSK plc
Similarity is computed from the 8 composite sub-scores and latest-quarter 13F conviction holdings (index-style filers excluded). Refreshed monthly.
More Healthcare Companies
View all Healthcare →Put EMBC on your watchlist
Track score changes the day Embecta Corp. files with the SEC, follow the hedge funds that own it, screen 2,800+ AI-scored stocks, and get the daily brief — free.
Free tier includes 13F data, economic indicators, and market overview. Pro starts at $6.67/mo (billed annually).
Popular Research
Is EMBC a good stock to buy?
13F Pro's AI-powered analysis of Embecta Corp. (EMBC) draws on SEC EDGAR-sourced fundamentals, institutional 13F holdings, and insider Form 4 transactions in the Healthcare sector (listed on Nasdaq). The 32-signal AI Quality Score, current rank, and full bull/bear verdict for EMBC are available on the EMBC stock profile dashboard — with the same data, AI insights, ratios, and institutional activity refreshed after every 10-K, 10-Q, 13F, and Form 4 filing. EMBC is classified as a small company.
Which hedge funds own EMBC?
Institutional investors are required to disclose their holdings quarterly via SEC Form 13F. 13F Pro aggregates these filings to show which hedge funds, mutual funds, and asset managers are buying or selling EMBC. Combined with insider transaction data from Form 4 filings and AI-powered analysis from 10 specialized research agents, 13F Pro provides a comprehensive view of Embecta Corp.'s investment landscape.